PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2019.00652019336506Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous ChorioretinopathySung Rae Noh, Min Seok Kang, Kiyoung Kim, Eung Suk Kim, Seung-Young Yuhttps://synapse.koreamed.org/pdf/10.3341/kjo.2019.0065, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2019.0065, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2019.0065
Pharmaceuticals10.3390/ph1311034920201311349Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and EfficacyPierluigi Iacono, Stefano Da Pozzo, Monica Varano, Mariacristina Parravanohttps://www.mdpi.com/1424-8247/13/11/349/pdf
Acta Ophthalmologica Scandinavica10.1111/j.1600-0420.2007.01062_3402.x2007850-0Photodynamic therapy with Verteporfin combined with intravitreal injection of Bevacizumab for central serous chorioretinopathyM MAIERhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0420.2007.01062_3402.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0420.2007.01062_3402.x/fullpdf
10.21203/rs.3.rs-146495/v12021Decrease in Choroidal Blood Flow After Half and One-Third Dose Verteporfin Photodynamic Therapy For Chronic Central Serous Chorioretinopathyshun kumashiro, seiji takagi, takashi itokawa, akiko tajima, tatsuhiko kobayashi, yuichi horihttps://www.researchsquare.com/article/rs-146495/v1, https://www.researchsquare.com/article/rs-146495/v1.html
Clinical Ophthalmology10.2147/opth.s586172014685Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathyZeynep Alkin, Irfan Perente, Abdullah Ozkaya, Dilek Yasa, Alper Agca, Ebru Demet Aygit, Selcuk Korkmaz, Ahmet Taylan Yazici, Ahmet Demirokhttps://www.dovepress.com/getfile.php?fileID=19556
Central Serous Chorioretinopathy10.1016/b978-0-12-816800-4.00019-x2019283-292Photodynamic Therapy in Central Serous ChorioretinopathyCamiel J.F. Boon, Elon H.C. van Dijk, Suzanne Yzerhttps://api.elsevier.com/content/article/PII:B978012816800400019X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B978012816800400019X?httpAccept=text/plain
Clinical Ophthalmology10.2147/opth.s9574820152257Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathyYosanan Yospaiboon, Thuss Sanguansak, Prapapan Pitujaturont, Suthasinee Sinawat, Tanapat Ratanapakorn, Chavakij Bhoomibunchoohttps://www.dovepress.com/getfile.php?fileID=28218
Journal of the Korean Ophthalmological Society10.3341/jkos.2009.50.9.132620095091326Photodynamic Therapy With Verteporfin using Half Fluence for Chronic Central Serous ChorioretinopathyMun Hee Chang, Seong Woo Kim, Jae Ryung Oh, Kuhl Huhhttps://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2009.50.9.1326, https://synapse.koreamed.org/pdf/10.3341/jkos.2009.50.9.1326, http://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2009.50.9.1326
Acta Ophthalmologica10.1111/j.1755-3768.2008.649.x2008860-0Photodynamic therapy without verteporfin for central serous chorioretinopathyAJ MATEO OROBIA, J IBANEZ ALPERTE, A SALINAS ALAMAN, J MATEO GABAS, N LAFUENTE, JA CRISTOBALhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2008.649.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2008.649.x/fullpdf
Journal of Clinical Medicine10.3390/jcm912398020209123980Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic TherapyKyoko Fujita, Kei Shinoda, Yutaka Imamura, Celso Soiti Matsumoto, Koichi Odahttps://www.mdpi.com/2077-0383/9/12/3980/pdf